Biography
Pursuant to the Order of the Grand Court of the Cayman Islands (the “Order”), the powers of the existing Directors of Global Cord Blood Corporation (“GCBC”) are suspended.
The Joint Provisional Liquidators (“JPLs”) of GCBC have appointed corporate director entities controlled by the JPLs as directors to GCBC and its known subsidiaries.
Link to the Order made by the Grand Court of the Cayman Islands: https://www.sec.gov/Archives/edgar/data/1467808/000110465922102999/tm2226635d1_ex99-1.htm
Mr. CHEN Mark D.
Independent Non-executive Director
Mr. Mark D. Chen, serves as one of our independent non-executive directors and also chairman of the Special Committee. Prior to the Business Combination on June 30, 2009, Mr. Chen was Pantheon’s chairman of the board, chief executive officer and president since its inception in 2006. He is among the earliest investors and sponsors of SPAC, and have been actively engaged in advisory of SPAC investment, formation and transaction since 2003. He has extensive experience in private equity investments in a wide range of industries globally including life science and healthcare, TMT, semiconductor and real estate through numerous investment vehicles and funds. In 1998, Mr. Chen co-founded Easton Capital Investment Group, a firm focusing on U.S. based life science venture investments. He is currently an independent non-executive board director of Megain Holding (Cayman) Co., Ltd (6939.HK). Mr. Chen received a B.S. from the Shanghai Jiao Tong University in Shanghai, China, an M.S. from Pennsylvania State University and an M.B.A. from the Columbia Business School at Columbia University.